Berberine suppresses inflammatory agents-induced interleukin-1β and tumor necrosis factor-α productions via the inhibition of IκB degradation in human lung cells

Pharmacological Research

Volumn 56, Issue 3, 2007, Pages 193-201

  Lee, Chang Hsien ^a   Chen, Jaw Chyun ^a   Hsiang, Chien Yun ^a   Wu, Shih Lu ^a   Wu, Hsiu Ching ^a   Ho, Tin Yun ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Berberine; Inhibitory B ; Interleukin 1 ; Pulmonary inflammation; Tumor necrosis factor

Indexed keywords

ANTIINFLAMMATORY AGENT; BERBERINE; CERAMIDE; CHELERYTHRINE; HYDROGEN PEROXIDE; I KAPPA B; I KAPPA B ALPHA; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; OKADAIC ACID; PHORBOL 13 ACETATE 12 MYRISTATE; SANGUINARINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CYTOKINE PRODUCTION; DOSE RESPONSE; FIBROBLAST; HUMAN; HUMAN CELL; INFLAMMATION; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LYMPHOMA CELL; PHOSPHORYLATION; PLANT; PRIORITY JOURNAL; PROTEIN DEGRADATION;

ALKALOIDS; ANTI-INFLAMMATORY AGENTS; BENZOPHENANTHRIDINES; BERBERINE; CELL SURVIVAL; CERAMIDES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FIBROBLASTS; HUMANS; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; INFLAMMATION; INTERLEUKIN-1BETA; ISOQUINOLINES; LIPOPOLYSACCHARIDES; LUNG; OKADAIC ACID; PHOSPHORYLATION; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA; U937 CELLS;

EID: 34548206790     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2007.06.003     Document Type: Article

References (54)

1. Kallapur S.G., and Jobe A.H. Contribution of inflammation to lung injury and development. Arch Dis Child Fetal Neonatal Ed 91 (2006) F132-F135
2. Lamkhioued B., Renzi P.M., Abi-Younes S., Garcia-Zepada E.A., Allakhverdi Z., Ghaffar O., et al. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. J Immunol 159 (1997) 4593-4601
3. Haddad J.J., and Land S.C. Amiloride blockades lipopolysaccharide-induced proinflammatory cytokine biosynthesis in an IκB-α/NF-κB-dependent mechanism. Evidence for the amplification of an antiinflammatory pathway in the alveolar epithelium. Am J Respir Cell Mol Biol 26 (2002) 114-126
4. Teran L.M., Mochizuki M., Bartels J., Valencia E.L., Nakajima T., Hirai K., et al. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts. Am J Respir Cell Mol Biol 20 (1999) 777-786
5. Baldwin Jr. A.S. The NF-κB and IκB proteins: new discoveries and insights. Annu Rev Immunol 14 (1996) 649-683
6. Barnes P.J., and Karin M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336 (1997) 1066-1071
7. Baeuerle P.A., and Baichwal V.R. NF-κB as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 65 (1997) 111-137
8. Lilly C.M., Nakamura H., Kesselman H., Nagler-Anderson C., Asano K., Garcia-Zepeda E.A., et al. Expression of eotaxin by human lung epithelial cells: induction by cytokines and inhibition by glucocorticoids. J Clin Invest 99 (1997) 1767-1773
9. Doherty A.M. Phosphodiesterase 4 inhibitors as novel anti-inflammatory agents. Curr Opin Chem Biol 3 (1999) 466-473
10. Haskó G., Kuhel D.G., Nemeth Z.H., Mabley J.G., Stachlewitz P.F., Virag L., et al. Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164 (2000) 1013-1019
11. Makins R., and Ballinger A. Gastrointestinal side effects of drugs. Expert Opin Drug Saf 2 (2003) 421-429
12. Yamamoto Y., and Gaynor R.B. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J Clin Invest 107 (2001) 135-142
13. Schmeller T., Latz-Bruning B., and Wink M. Biochemical activities of berberine, palmaltine and sanguinarine mediating chemical defense against microorganisms and herbivores. Phytochemistry 44 (1997) 257-266
14. Walterova D., Ulrichova J., Valka I., Vicar J., Vavreckova C., Taborska E., et al. Benzo[c]phenanthridine alkaloids sanguinarine and chelerythrine: biological activities and dental care applications. Acta Univ Palacki Olomuc Fac Med 139 (1995) 7-16
15. Kuo C.L., Chi C.W., and Liu T.Y. The anti-inflammatory potential of berberine in vitro and in vivo. Cancer Lett 203 (2004) 127-137
16. Chaturvedi M.M., Kumar A., Darnay B.G., Chainy G.B., Agarwal S., and Aggarwal B.B. Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation. J Biol Chem 272 (1997) 30129-30134
17. Hsiang C.Y., Wu S.L., Cheng S.E., and Ho T.Y. Acetaldehyde-induced interleukin-1β and tumor necrosis factor-α production is inhibited by berberine through nuclear factor-κB signaling pathway in HepG2 cells. J Biomed Sci 12 (2005) 791-801
18. Hsiang C.Y., Wu S.L., and Ho T.Y. Morin inhibits 12-o-tetradecanoylphorbol-13-acetate-induced hepatocellular transformation via activator protein 1 signaling pathway and cell cycle progression. Biochem Pharmacol 69 (2005) 1603-1611
19. Chung K.F. Cytokines in chronic obstructive pulmonary disease. Eur Respir J Suppl 34 (2001) 50s-59s
20. Michel O. Role of lipopolysaccharide (LPS) in asthma and other pulmonary conditions. J Endotoxin Res 9 (2003) 293-300
21. Boles B.K., Ritzenthaler J.Y., Birkenmeier T., and Roman J. Phorbol ester-induced U-937 differentiation: effects on integrin α(5) gene transcription. Am J Physiol Lung Cell Mol Physiol 278 (2000) L703-L712
22. Kinnula V.L., Crapo J.D., and Raivio K.O. Generation and disposal of reactive oxygen metabolites in the lung. Lab Invest 73 (1995) 3-19
23. Sonoda Y., Kasahara T., Yamaguchi Y., Kuno K., Matsushima K., and Mukaida N. Stimulation of interleukine-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-κB activation. J Biol Chem 272 (1997) 15366-15372
24. Zimmerman G.A., and McIntyre T.M. PAF, ceramide and pulmonary edema: alveolar flooding and a flood of questions. Trends Mol Med 10 (2004) 245-248
25. Hannun Y.A. The sphingomyelin cycle and the second messenger function of ceramide. J Biol Chem 269 (1994) 3125-3128
26. Dinarello C.A. Biologic basis for interleukin-1 in disease. Blood 87 (1996) 2095-2147
27. Zeidel A., Beilin B., Yardeni I., Mayburd E., Smirnov G., and Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand 46 (2002) 959-964
28. Castro P., Legora-Machado A., Cardilo-Reis L., Valen S., Porto L.C., Walker C., et al. Inhibition of interleukin-1β reduces mouse lung inflammation induced by exposure to cigarette smoke. Eur J Pharmacol 498 (2004) 279-286
29. Sousa A.R., Lane S.J., Nakhosteen J.A., Lee T.H., and Poston R.N. Expression of interleukin-1β (IL-1β) and interleukin-1 receptor antagonist (IL-1ra) on asthmatic bronchial epithelium. Am J Respir Crit Care Med 154 (1996) 1061-1066
30. Driscoll K.E. TNF-α and MIP-2: role in particle-induced inflammation and regulation by oxidative stress. Toxicol Lett 112/113 (2000) 177-183
31. Di F.M., Barbier D., Mege J.L., and Orehek J. Tumor necrosis factor-α levels and weight loss in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 150 (1994) 1453-1455
32. Rahman I., Gilmour P.S., Jimenez L.A., and MacNee W. Oxidative stress and TNF-α induce histone acetylation and NF-κB/AP-1 activation in alveolar epithelial cells: potential mechanism in gene transcription in lung inflammation. Mol Cell Biochem 234/235 (2002) 239-248
33. Riise G.C., Larsson S., Lofdahl C.G., and Andersson B.A. Circulating cell adhesion molecules in bronchial lavage and serum in COPD patients with chronic bronchitis. Eur Respir J 7 (1994) 1673-1677
34. Zandi E., Rothwarf D.M., Delhase M., Hayakawa M., and Karin M. The IκB kinase complex (IKK) contains two kinase subunits, IKKα and IKKβ, necessary for IκB phosphorylation and NF-κB activation. Cell 91 (1997) 243-252
35. Covert M.W., Leung T.H., Gaston J.E., and Baltimore D. Achieving stability of lipopolysaccharide-induced NF-κB activation. Science 309 (2005) 1854-1857
36. Schoonbroodt S., Ferreira V., Best-Belpomme M., Boelaert J.R., Legrand-Poels S., Korner M., et al. Crucial role of amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of IκB-α in NF-κB activation by an oxidative stress. J Immunol 164 (2000) 4292-4300
37. Sonoda Y., Kasahara T., Yamaguchi Y., Kuno K., Matsushima K., and Mukaida N. Stimulation of interleukin-8 production by okadaic acid and vanadate in a human promyelocyte cell line, an HL-60 subline. Possible role of mitogen-activated protein kinase on the okadaic acid-induced NF-κB activation. J Biol Chem 272 (1997) 15366-15372
38. Morimoto H., Ozaki A., Okamura H., Yoshida K., Kitamura S., and Haneji T. Okadaic acid induces tyrosine phosphorylation of IκBα that mediated by PKR pathway in human osteoblastic MG63 cells. Mol Cell Biochem 276 (2005) 211-217
39. Boland M.P., and O'Neill L.A.J. Ceramide activates NF-κB by inducing processing of p105. J Biol Chem 273 (1998) 15494-15500
40. Šimánek V. Benzophenanthridine alkaloids. In: Brossi A. (Ed). The alkaloids vol. 26 (1985), Academic Press, New York 185-240
41. Ahsan H., Reagan-Shaw S., Breur J., and Ahmad N. Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Lett 249 (2007) 198-208
42. Herbert J.M., Augereau J.M., Gleye J., and Maffrandm J.P. Chelerythrine is a potent and specific inhibitor of protein kinase C. Biochem Biophy Res Commun 172 (1990) 993-999
43. Duvoix A., Delhalle S., Blasius R., Schnekenburger M., Morceau F., Fougère M., et al. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition. Biochem Pharmacol 68 (2004) 1101-1111
44. Dvořák Z., Sovadinová I., Bláha L., Giesy J.P., and Ulrichová J. Quaternary benzo[c]phenathridine alkaloids sanguinarine and chelerythrine do not affect transcriptional activity of aryl hydrocarbon receptor: analyses in rat hepatoma cell line H4IIE.luc. Food Chem Toxicol 44 (2006) 1466-1473
45. Zdařilová A., Vrzal R., Rypka M., Ulrichová J., and Dvořák Z. Investigation of sanguinarine and chelerythrine effects on CYP1A1 expression and activity in human hepatoma cells. Food Chem Toxicol 44 (2006) 242-249
46. Malíková J., Zdařilová J., Hlobilková A., and Ulrichová J. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine. Cell Biol Toxicol 22 (2006) 439-453
47. Ikram M. A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28 (1975) 353-358
48. Kettmann V., Kosfalova D., Jantova S., Cernakova M., and Drimal J. In vitro cytotoxicity of berberine against HeLa and L1210 cancer cell lines. Pharmazie 59 (2004) 548-551
49. Mitani N., Murakami K., Yamaura T., Ikeda T., and Saiki I. Inhibitory effect of berberine on the mediastinal lymph node metastasis produced by orthotropic implantation of Lewis lung carcinoma. Cancer Lett 165 (2001) 35-42
50. Fukuda K., Hibiya Y., Mutoh M., Koshiji M., Akao S., and Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Enthopharmacol 66 (1999) 227-233
51. Lee D.U., Kang Y.J., Park M.K., Lee Y.S., Seo H.G., Kim T.S., et al. Effects of 13-alkyl-substituted berberine alkaloids on the expression of COX-II, TNF-α, iNOS, and IL-12 production in LPS-stimulated macrophages. Life Sci 73 (2003) 1401-1412
52. Dvořák Z., Vrzal R., Maurel P., and Ulrichová J. Differential effects of selected natural compounds with anti-inflammatory activity on the glucocorticoid receptor and NF-κB in HeLa cells. Chem Biol Interact 159 (2006) 117-128
53. Li B.X., Zhang M.S., and Bao L.H. Study on the pharmacokinetics of berberine after oral administration in human being. Harbin Med Univ J 29 (1995) 382-385
54. Vrzal R., Zdařilová A., Ulrichová J., Bláha L., Giesy J.P., and Dvořák Z. Activation of the aryl hydrocarbon receptor by berberine in HepG2 and H4IIE cells: biphasic effect on CYP1A1. Biochem Pharmacol 70 (2005) 925-936